Researchers have found a new way to boost cancer immunotherapy by targeting a protein called macrophage receptor with collagenous structure, or MARCO. Their study shows that blocking MARCO in ...
Astellas Pharma’s strong pipeline and revenue growth support a positive outlook. See why ALPMF stock is a "Buy," driven by ...
Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.
Panel recommends ICMR to hold inter-ministerial consultation on patent duration: Gireesh Babu, New Delhi Saturday, March 15, 2025, 08:00 Hrs [IST] The Parliamentary Panel on Healt ...
Leap Therapeutics (NASDAQ:LPTX – Get Free Report) is anticipated to announce its earnings results before the market opens on Monday, March 17th. Analysts expect the company to announce earnings of ($0 ...
Equities research analysts at William Blair issued their FY2029 earnings per share (EPS) estimates for shares of Genmab A/S ...
Genmab wisely chose not to pursue GEN3014 further, focusing instead on its existing pipeline projects. Click here to read an ...
12h
Tribune Online on MSNFinding cure for cancer inspired me to become a research pharmacist—Izuchukwu Okpalanwaka, Nigerian US-based pharmacist, doctoral candidateIzuchukwu Okpalanwaka is a pharmacist and a doctoral researcher at the Texas Tech University Health Science Center (TTUHSC), United States. He is also the co-founder of the Tropical Medical Oncology ...
Alternative RNA splicing is like a movie editor cutting and rearranging scenes from the same footage to create different ...
16h
SanDiegoRed on MSNHow Immunotherapy is Revolutionizing Stage 4 Cancer TreatmentF or patients diagnosed with stage 4 cancer, a condition often accompanied by limited treatment options and grim prognoses, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results